Skip to main content
Home » What's New » New AREDS Study of Macular Degeneration

New AREDS Study of Macular Degeneration

The AREDS 2 study results are in:

  • The only subgroup which showed a benefit of adding more lutein and zeaxanthin to the current recommended dosage, were those patients who were in the lowest quintile of dietary consumption of lutein and zeaxanthin.
  • The most appropriate recommendation for most patients is incorporate sources of lutein and zeaxanthin into their diet.
  • Omega 3 fatty acids were also shown to have no effect on macular degeneration, when added to the ocular vitamins.

 

 

For specific information about AREDS2, visit www.nei.nih.gov/areds2

July 12 Card 5×7

x

WOW! Voted Best of Reno in the RN&R 13th Year in a row